Cryo-Cell International Inc.
$4.00
-$0.25 (-5.88%)
$4.00Day Range$4.35
Key Statistics
Market Cap
$34.27M
Shares Outstanding
8.1M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
—
Round Lot
100
Locale
US
Trading Data
Day Open
$4.17
Day High
$4.35
Day Low
$4.00
Volume
2.8K
VWAP
$4.14
Prev Close
$4.25
Transactions
--
Acc. Volume
--
About Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
SERVICES-MISC HEALTH & ALLIED SERVICES, NECSIC 809076 employees700 BROOKER CREEK BLVD, OLDSMAR, FL, 34677813-749-2104US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000862692
- Composite FIGI
- BBG000BS6ZT0
- Share Class FIGI
- BBG001S6Z7X3
- Ticker Root
- CCEL
- SIC Code
- 8090
About Cryo-Cell International Inc. (CCEL) Stock
Cryo-Cell International Inc. (CCEL) closed the 2026-09-18 session at $4.00, down 5.88% versus the previous close (-0.25). The stock opened at $4.17 and traded between $4.00 and $4.35 during that session. Session trading volume was 3K shares. The volume-weighted average price (VWAP) is $4.14.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Cryo-Cell International Inc. has a market capitalization of $34.3 million. The company operates in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry classification. CCEL is listed on the XASE exchange. The company employs approximately 76 people. Cryo-Cell International Inc. is headquartered in OLDSMAR, FL.
On this page you can find market CCEL stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector.